Search by First Name and/or Last Name. Results are displayed in descending publication year and then sorted ascending by the reference field. Need to submit a publication reference?


Researcher Publication Search Form

Name: Anne Fagan
Year: 2013

Reference:

Winer L, Srinivasan D, Chun S, Lacomis D, Jaffa M, Fagan A, Holtzman DM, Wancewicz E, Bennett CF, Bowser R, Cudkowicz M, Miller TM. SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy. JAMA Neurol. 2013 Feb;70(2):201-7. Doi 10.1001/jamaneurol.2013.593. PMID: 23147550 [PubMed – indexed for MEDLINE]

Name: Alison Goate
Year: 2013

Reference:

Zou F, Belbin O, Carrasquillo MM, Culley OJ, Hunter TA, Ma L, Bisceglio GD, Allen M, Dickson DW, Graff-Radford NR, Petersen RC; Genetic and Environmental Risk for Alzheimer’s disease (GERAD1) Consortium, Morgan K, Younkin SG. Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer’s disease pathology. PLoS One 2013: 8(5):e64802. PMCID: PMC3665686

Name: Beau Ances
Year: 2012

Reference:

Ances BM, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, Aldea P, Fagan AM, Holtzman DM, Morris JC, Clifford DB. 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Arch Neurol. 2012 Jan;69(1):72-7. PMCID: PMC3536500.

Name: Anne Fagan
Year: 2012

Reference:

Ances BM, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, Aldea P, Fagan AM, Holtzman DM, Morris JC, Clifford DB. 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Archives of Neurology, 2012 Jan;69: 72-7. PMCID: PMC3536500

Name: Anne Fagan
Year: 2012

Reference:

Ances BM, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, Aldea P, Fagan AM, Holtzman DM, Morris JC, Clifford DB. 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Archives of Neurology, 2012 Jan;69: 72-7. PMCID:PMC3536500

Name: Beau Ances
Year: 2012

Reference:

Ances, B.M., Benzinger, T.L., Christensen, J.J., Thomas, J., Venkat, R., Teshome, M., Aldea, P., Fagan, A.M., Holtzman D.M., Morris, J.C., Clifford, D.B. (2012) HIV Associated Neurocognitive Disorder (HAND) is Not Associated with Increased Fibrillar Amyloid Deposits Using 11C-PiB in Middle-Aged HIV+ Participants. Arch Neurol., 69(1):72-7. PMCID: PMC3536500

Name: Nigel Cairns
Year: 2012

Reference:

Armstrong RA, Cairns NJ. Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disorders. J Neural Transm. 2012 Jun 8. [Epub ahead of print]
PMID: 22678700

Name: Jeffrey Zacks
Year: 2012

Reference:

Bailey, H. R., Zacks, J. M., Hambrick, D. Z., Zacks, R. T., Head, D., Kurby, C. A., & Sargent, J. Q. (in press). Medial temporal lobe volume predicts elders’ everyday memory. Psychological Science.

Name: David Balota
Year: 2012

Reference:

Bangert AS, Abrams RA, Balota DA. Reaching for words and nonwords: Interactive effects of word frequency and stimulus quality on the characteristics of reaching movements. Psychonomic Bulletin & Review 2012; 19(3): 513-520. PMID: 22419404. [PubMed – as supplied by publisher]

Name: David Balota
Year: 2012

Reference:

Bangert AS, Balota DA. Keep up the Pace: Declines in simple repetitive timing differentiates healthy aging from the earliest stages of Alzheimer’s disease. Journal of the International Neuropsychological Society 2012; 18(6): 1052-1063. PMCID: PMC3505757.

Name: Anne Fagan
Year: 2012

Reference:

Bateman R, Xiong C, Benzinger T, Fagan A, Goate A, Fox N, Marcus D, Cairns N, Xie X, Blazey T, Holtzman D, Santacruz A, Buckles V, Oliver A, Moulder K, Ghetti B, Klunk W, McDade E, Martins R, Masters C, Mayeux R, Ringman J, Rossor M, Schofield P, Sperling R, Salloway S, Morris J and on behalf of the Dominantly Inherited Alzheimer Network (DIAN) Clinical, cognitive, and biomarker changes in the Dominantly Inherited Alzheimer Network). New England Journal of Medicine 2012, Jul 11. PMCID: PMC3474597

Name: Nigel Cairns
Year: 2012

Reference:

Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC; Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012 Aug 30;367(9):795-804. Epub 2012 Jul 11. Erratum in: N Engl J Med. 2012 Aug 23;367(8):780. PMC3474597

Name: Catherine Roe
Year: 2012

Reference:

Behrens MI, Silva M, Salech F, Merino D, Ponce DP, Sinning M, Xiong C, Roe CM, Quest AFG. Journal of Gerontology: Biological Sciences. (In press).

Name: Anne Fagan
Year: 2012

Reference:

Blennow K, Zetterberg H, Fagan A. Fluid biomarkers in AD. In: Biology of AD, Selkoe D, Holtzman D, Mandelkow E, eds., Cold Spring Harbor Laboratory Press: New York, pgs. 91-113, 2012.

Name: Nigel Cairns
Year: 2012

Reference:

Boxer AL, Gold M, Huey E, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian Z, Sutherland M, Farese R, Miller BL, Cummings J. Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development.Alzheimers Dement. 2012 Oct 5. pii: S1552-5260(12)01750-5. PMID:23043900

Name: Nigel Cairns
Year: 2012

Reference:

Boxer AL, Gold M, Huey E, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian Z, Sutherland M, Farese R, Miller BL, Cummings J.Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement. 2012 Oct 5. doi:pii: S1552-5260(12)01750-5. 10.1016/j.jalz.2012.03.002. PMC3542408

Name: Nigel Cairns
Year: 2012

Reference:

Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Jackson G, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian ZS, Sutherland M, Abushakra S, Lewcock J, Farese R, Kenet RO, Laferla F, Perrin S, Whitaker S, Honig L, Mesulam MM, Boeve B, Grossman M, Miller BL, Cummings JL. The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier).Alzheimers Dement. 2012 Oct 9. pii: S1552-5260(12)01751-7. PMID:23062850

Name: alison goate
Year: 2012

Reference:

Cruchaga C, Chakraverty S, Mayo K, Vallania FL, Mitra RD, Faber K, Williamson J, Bird T, Diaz-Arrastia R, Foroud TM, Boeve BF, Graff-Radford NR, St Jean P, Lawson M, Ehm MG, Mayeux R, Goate AM; for the NIA-LOAD/NCRAD Family Study Consortium. Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer’s Disease Families. PLoS One. 2012; 7(2):e31039. PMCID: 3270040

Name: Anne Fagan
Year: 2012

Reference:

Cruchaga C, Kauwe JS, Nowotny P, Bales K, Pickering EH, Mayo K, Bertelsen S, Hinrichs A; the Alzheimer’s Disease Neuroimaging Initiative, Fagan AM, Holtzman DM, Morris JC, Goate AM. Cerebrospinal fluid APOE levels, an endophenotype for genetic studies for Alzheimer’s disease. Human Molecular Genetics. 2012 Jul 20. PMCID:PMC3459471

Name: Yvette Sheline
Year: 2012

Reference:

Disabato BM, Hranilovich J, Morris C, D’Angelo G, Wu N, Doraiswamy PM, and Sheline YI. A Comparison of Brain Structural Variables, Neuropsychological Factors, and Treatment Outcome in Early Versus Late Onset Late Life Depression. The American Journal of Geriatric Psychiatry. In press.

Name: Brianne Disabato
Year: 2012

Reference:

Disabato BM, Sheline YI. Biological Basis of Late Life Depression. Curr Psychiatry Rep. 2012 May 6

Name: Nigel Cairns
Year: 2012

Reference:

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain.Sun J, Xu J, Cairns NJ, Perlmutter JS, Mach RH.PLoS One. 2012;7(11):e49483. doi: 10.1371/journal.pone.0049483. Epub 2012 Nov 21.PMC3504049

Name: Anne Fagan
Year: 2012

Reference:

Fagan AM, Perrin RJ; Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease Biomarkers in Medicine. 2012 Aug;6(4):455-76 PMID: 22917147 PMCID: PMC3477809

Name: Anne Fagan
Year: 2012

Reference:

Fagan AM, Perrin RJ; Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease Biomarkers in Medicine. 2012 Aug;6(4):455-76 PMID: 22917147 PMCID: PMC3477809

Name: alison goate
Year: 2012

Reference:

Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Kölsch H, Heun R, Schürmann B, Bussche HV, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Davies G, Harris SE, Starr JM, Deary IJ, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Jones L, Holmans PA, O’Donovan MC, Owen MJ, Williams J. The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer’s Disease. J Alzheimers Disease 2012; 28(2): 377-87.